Platinum-based Chemoradiotherapy and Rigosertib in Head and Neck Cancer

NCT02107235 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Head and Neck Neoplasms
Carcinoma, Squamous Cell

Interventions

DRUG: oral rigosertib
DRUG: cisplatin
RADIATION: Radiotherapy

Sponsor

Traws Pharma, Inc.